top of page
Nelson Advisors > European HealthTech & MedTech


Biological Intelligence: Strategic Rationale for Anthropic's $400 Million Acquisition of Coefficient Bio
The acquisition of Coefficient Bio by Anthropic in April 2026, valued at slightly more than $400 Million in an all stock transaction, represents a fundamental shift in the strategic deployment of frontier artificial intelligence. While the acquisition involves a team of fewer than ten people, translating to a valuation of approximately $40 Million to $44 Million per employee, the transaction’s importance transcends typical talent acquisition metrics.
5 hours ago11 min read
bottom of page